The interface of medical devices and pharmaceuticals: Part I.
This two-part article considers the complexities of developing and commercialising combination products using examples from experience with drug-eluting stents and drug-eluting beads. Part I discusses the technical challenges of developing these products.
Willis
S L
SL
Biocompatibles UK Ltd, Farnham, UK. sean.willis@biocompatibles.com
Lewis
A L
AL
D001672:Biocompatible Materials; D016503:Drug Delivery Systems; D054855:Drug-Eluting Stents; D004864:Equipment and Supplies; D006801:Humans
D001672:Biocompatible Materials